by Phil Calvin | November 30, 2020
Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader in enterprise software, with more than 25 years of entrepreneurial and executive experience, including nearly a decade at Salesforce.
by Joe DePinto | November 23, 2020
Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader in cell and gene therapies, and a veteran biotech and pharma executive with more than 28 years of experience.
by Amy DuRoss | November 17, 2020
A Vineti technology perspective from CEO and Co-founder Amy DuRoss
by Amy DuRoss | October 7, 2020
by Heidi Hagen and Christophe Suchet | February 21, 2020
This post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell therapies, gene therapies, or neoantigen cancer vaccines.